DG
EXAS

Doman Group’s Exact Sciences EXAS Stock Holding History

Doman Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$836K Buy
+10,743
New +$948K 0.73% 48

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Doman Group's EXAS Position: Q4 2021 in Review

Doman Group opened a new position in Exact Sciences (EXAS) in Q4 2021: 10,743 shares worth $836K. The stake represents 0.73% of the portfolio and ranks #48 among its holdings.

595 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Doman Group held 10,743 shares of Exact Sciences worth $836K as of Q4 2021.
  • Exact Sciences was a new Doman Group position in Q4 2021.
  • Exact Sciences made up 0.73% of Doman Group's portfolio in Q4 2021, its #48 holding.
  • 595 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Doman Group's 13F filing for Q4 2021, filed 14 Mar 2022.